XETRA - Delayed Quote EUR

Vertex Pharmaceuticals Incorporated (VX1.DE)

Compare
447.30 -1.70 (-0.38%)
At close: October 18 at 5:35 PM GMT+2

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

19.6

Negligible

Environmental Risk Score

0.9

Social Risk Score

13.7

Governance Risk Score

5.0

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
QTRX Quanterix Corporation 20 -- -- --
BKD.SG Bruker Corp. 20 2 12 6
VX1.DE VERTEX PHARMAC. DL-,01 20 1 14 5
RV7.F HALOZYME THERAPEU.DL-,001 20 -- -- --
NG9.F NEOGENOMICSINC. DL-,001 20 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
VX1.DE
Category Average
2 Moderate Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers